Aquestive Therapeutics, Inc. Loss Contingency, New Claims Filed, Number
Aquestive Therapeutics, Inc. (AQST) reported Loss Contingency, New Claims Filed, Number of 4 Case for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-04.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Quantities
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2020-11-04
- Aquestive Therapeutics, Inc. loss contingency, new claims filed, number for the quarter ending 2020-03-31 was 4.00 Case, a 0.00% change year-over-year.
- Aquestive Therapeutics, Inc. loss contingency, new claims filed, number for the quarter ending 2019-03-31 was 4.00 Case.
- Aquestive Therapeutics, Inc. loss contingency, new claims filed, number for fiscal 2019 was 4.00 Case, a 33.33% increase from fiscal 2018.
- Aquestive Therapeutics, Inc. loss contingency, new claims filed, number for fiscal 2018 was 3.00 Case.
| Period end | Loss Contingency, New Claims Filed, Number 3 month | Loss Contingency, New Claims Filed, Number 6 month | Loss Contingency, New Claims Filed, Number 9 month | Loss Contingency, New Claims Filed, Number 12 month |
|---|---|---|---|---|
| 2020-09-30 | 4.00 Case 10-Q · filed 2020-11-04 | |||
| 2020-06-30 | 4.00 Case 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | 4.00 Case 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | 4.00 Case 10-K · filed 2020-03-11 | |||
| 2019-09-30 | 4.00 Case 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | 4.00 Case 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | 4.00 Case 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | 3.00 Case 10-K · filed 2019-03-14 | |||
| 2018-09-30 | 3.00 Case 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | 3.00 Case 10-Q · filed 2018-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |